We build the equipment that care depends on.
For more than four decades, Sungmoo has grown from a single production line in Seoul into an integrated medical technology manufacturer — engineering hospital and medical equipment, and select essential medicines, for healthcare systems worldwide.
Our work is guided by a simple conviction: that precision engineering, uncompromising quality and genuine care for patients are the same priority. From our ISO 13485 facilities in Osong and Hwaseong, we manufacture devices and medicines trusted by clinicians and hospitals across Asia, Europe and the Americas.
Hwaseong Device PlantFour areas, one purpose
Patient Monitoring
Multi-parameter monitors, ECG and vital-signs systems engineered for every level of acuity.
Imaging & Diagnostics
Ultrasound, digital radiography and point-of-care diagnostic systems for fast, accurate decisions.
Surgical & Critical Care
Operating-room systems, ventilators, defibrillators and infusion pumps for life-critical settings.
Hospital Infrastructure
Hospital beds, sterilisation, surgical lighting and the equipment that runs a modern ward.
A foundation built on scale and rigour
R&D Center · SeoulEngineering is where care begins
Our engineers and clinicians design medical devices for the moments that matter most — pairing hardware, embedded software and human-factors research with global clinical partnerships.
We invest around 13% of revenue back into R&D every year, sustaining a portfolio that ranges from next-generation patient monitors and imaging systems to connected, data-driven hospital technology.
Responsible by design
Environment
Carbon-neutral operations by 2040, with water stewardship and green chemistry across every site.
Society
Patient-access programmes, ethical sourcing and a safe, inclusive workplace for every employee.
Governance
Transparent oversight, independent directors and an uncompromising compliance culture.
Latest from Sungmoo
Sungmoo opens a new medical-device production line at the Hwaseong plant
Next-generation SGM Vesta patient monitor receives CE marking
2025 ESG Report published: Scope 1 & 2 emissions down 22% year-on-year
Distribution agreement brings Sungmoo imaging systems to three new EU markets
Building healthier futures, together.
Whether you are a healthcare partner, investor or future colleague, we would be glad to talk.